ApiJect Holdings, Inc., the parent company of ApiJect Systems, Corp., a medical technology public-benefit corporation transforming the fill and finish and delivery of injectable vaccines and medicines, announced that it had completed a US$111 million private round of investment. The new round was led by Royalty Pharma and Jefferies Financial Group (NYSE: JEF), which acquired a revenue interest in addition to equity.
Latham & Watkins LLP represents ApiJect Holdings, Inc. in the investment round with a corporate team led by New York partner Nathan Ajiashvili and Boston partner Daniel Hoffman, with Chicago associates Jana Kovich, Kristine LaVeau, and Autumn Schmidt. Advice was also provided on benefits & compensation matters by Washington, D.C. partner David Della Rocca and Chicago associate Victoria Wolfe; on tax matters by New York partner Eric Kamerman; on antitrust matters by Washington, D.C. counsel Joseph Simei; and on CFIUS matters by Washington, D.C. partner Jim Barker.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
